Delivery of astragalus polysaccharide by ultrasound microbubbles attenuate doxorubicin-induced cardiomyopathy in rodent animals

References

• Saini V. Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J Diabetes. 2010;107:111.
   Google Scholar
• Edelman S, Pettus J. Challenges associated with insulin therapy in type 2 diabetes mellitus. Am J Med. 2014;127(10):S11–S16.
   PubMed Web of Science ®Google Scholar
• Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57(4):660–671.
   PubMed Web of Science ®Google Scholar
• Evangelista I, Nuti R, Picchioni T, et al. Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy. Int J Mol Sci. 2019;20(13):3264.
   PubMed Web of Science ®Google Scholar
• Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21–28.
   PubMed Web of Science ®Google Scholar
• Goyal BR, Mehta AA. Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfuntion. Hum Exp Toxicol. 2013;32(6):571–590.
   PubMed Web of Science ®Google Scholar
• Dillmann WH. Diabetic Cardiomyopathy. Circ Res. 2019;124(8):1160–1162.
   PubMed Web of Science ®Google Scholar
• Fu J, Wang Z, Huang L, et al. Review of the botanical characteristics, phytochemistry, and pharmacology of astragalus membranaceus (Huangqi). Phytother Res. 2014;28(9):1275–1283.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang L, Xu H. Effect of Astragalus polysaccharide in treatment of diabetes mellitus: a narrative review. J Tradit Chin Med. 2019;39(1):133–138.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Meng G, Teng F, et al. Retracted: effects of astragalus polysaccharide on apoptosis of myocardial microvascular endothelial cells in rats undergoing hypoxia/reoxygenation by mediation of the PI3K/Akt/eNOS signaling pathway. J Cell Biochem. 2018;119(1):806–816.
   PubMed Web of Science ®Google Scholar
• Liu D, Chen L, Zhao J, et al. Cardioprotection activity and mechanism of Astragalus polysaccharide in vivo and in vitro. Int J Biol Macromol. 2018;111:947–952.
   PubMed Web of Science ®Google Scholar
• Frinking P, Segers T, Luan Y, et al. Three decades of ultrasound contrast agents: a review of the past, present and future improvements. Ultrasound Med Biol. 2020;46(4):892–908.
   PubMed Web of Science ®Google Scholar
• Kang ST, Yeh CK. Ultrasound microbubble contrast agents for diagnostic and therapeutic applications: current status and future design. Chang Gung Med J. 2012;35(2):125–139.
   PubMedGoogle Scholar
• !!! INVALID CITATION !!! {}.
   Google Scholar
• Qu X, Zhang Z, Hu W, et al. Attenuation of the Na/K‑ATPase/Src/ROS amplification signaling pathway by astaxanthin ameliorates myocardial cell oxidative stress injury. Mol Med Rep. 2020;22(6):5125–5134.
   PubMed Web of Science ®Google Scholar
• Ueno H, Ito R, Abe SI, et al. SCO-267, a GPR40 full agonist, improves glycemic and body weight control in rat models of diabetes and obesity. J Pharmacol Exp Ther. 2019;370(2):172–181.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang L, Fan X, et al. Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/β-catenin and Jak2/Stat3 pathways. Biomed Pharmacother. 2019;113:108780.
   PubMed Web of Science ®Google Scholar
• Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624–638.
   PubMed Web of Science ®Google Scholar
• Luo J, Yan D, Li S, et al. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats. J Cell Mol Med. 2020;24(2):1760–1773.
   PubMed Web of Science ®Google Scholar
• Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12(3):144–153.
   PubMed Web of Science ®Google Scholar
• Hu J, Lu X, Zhang X, et al. Exogenous spermine attenuates myocardial fibrosis in diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress and the canonical Wnt signaling pathway. Cell Biol Int. 2020;44(8):1660–1670.
   PubMed Web of Science ®Google Scholar
• Li K, Zhai M, Jiang L, et al. Tetrahydrocurcumin ameliorates diabetic cardiomyopathy by attenuating high glucose-induced oxidative stress and fibrosis via activating the SIRT1 pathway. Oxid Med Cell Longev. 2019;2019:6746907.
   PubMed Web of Science ®Google Scholar
• Chang X, Lu K, Wang L, et al. Astraglaus polysaccharide protects diabetic cardiomyopathy by activating NRG1/ErbB pathway. Biosci Trends. 2018;12(2):149–156.
   PubMed Web of Science ®Google Scholar
• Ju J, Chen W, Lai Y, et al. Astragalus polysaccharides improve cardiomyopathy in STZ-induced diabetic mice and heterozygous (SOD2±) knockout mice. Braz J Med Biol Res. 2017;50(8):e6204.
   PubMed Web of Science ®Google Scholar
• Mao X-Q, Yu F, Wang N, et al. Hypoglycemic effect of polysaccharide enriched extract of Astragalus membranaceus in diet induced insulin resistant C57BL/6J mice and its potential mechanism. Phytomedicine. 2009;16(5):416–425.
   PubMed Web of Science ®Google Scholar
• Chen W, Chen W, Xia Y, et al. Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPARα mice. Mol Biol Rep. 2013;40(3):2449–2459.
   PubMed Web of Science ®Google Scholar
• Gu C, Zeng Y, Tang Z, et al. Astragalus polysaccharides affect insulin resistance by regulating the hepatic SIRT1-PGC-1α/PPARα-FGF21 signaling pathway in male Sprague Dawley rats undergoing catch-up growth. Mol Med Rep. 2015;12(5):6451–6460.
   PubMed Web of Science ®Google Scholar
• Chen SL, Hu ZY, Zuo GF, et al. I(f) current channel inhibitor (ivabradine) deserves cardioprotective effect via down-regulating the expression of matrix metalloproteinase (MMP)-2 and attenuating apoptosis in diabetic mice. BMC Cardiovasc Disord. 2014;14(1):150.
   PubMed Web of Science ®Google Scholar
• Sun S, Yang S, An N, et al. Astragalus polysaccharides inhibits cardiomyocyte apoptosis during diabetic cardiomyopathy via the endoplasmic reticulum stress pathway. J Ethnopharmacol. 2019;238:111857.
   PubMed Web of Science ®Google Scholar
• Liu Y, Miyoshi H, Nakamura M. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J Control Release. 2006;114(1):89–99.
   PubMed Web of Science ®Google Scholar
• Liang HD, Tang J, Halliwell M. Sonoporation, drug delivery, and gene therapy. Proc Inst Mech Eng H. 2010;224(2):343–361.
   PubMed Web of Science ®Google Scholar
• Ton N, Goncin U, Panahifar A, et al. Developing a microbubble-based contrast agent for synchrotron in-line phase contrast imaging. IEEE Trans Biomed Eng. 2021;68(5):1527–1535.
   PubMed Web of Science ®Google Scholar
• Meens MJ, Mattheij NJ, Nelissen J, et al. Calcitonin gene-related peptide terminates long-lasting vasopressor responses to endothelin 1 in vivo. Hypertension. 2011;58(1):99–106.
   PubMed Web of Science ®Google Scholar
• Clerico A, Zaninotto M, Passino C, et al. High-sensitivity methods for cardiac troponins: the mission is not over yet. Adv Clin Chem. 2021;103:215–252.
   PubMed Web of Science ®Google Scholar
• Halloran J, Lalande A, Zang M, et al. Monoclonal therapy against calcitonin gene-related peptide lowers hyperglycemia and adiposity in type 2 diabetes mouse models. Meta bolism open. 2020;8:100060.
   PubMedGoogle Scholar
• Sehnert B, Burkhardt H, Dübel S, et al. Cell-type targeted NF-kappaB inhibition for the treatment of inflammatory diseases. Cells. 2020;9(7):1627.
   PubMed Web of Science ®Google Scholar
• Lai XX, Zhang N, Chen LY, et al. Latifolin protects against myocardial infarction by alleviating myocardial inflammatory via the HIF-1α/NF-κB/IL-6 pathway. Pharm Biol. 2020;58(1):1156–1166.
   PubMed Web of Science ®Google Scholar
• Kaur N, Sharma AK, Shakeel A, et al. Therapeutic implications of superoxide dismutase and its importance in kinase drug discovery. Curr Top Med Chem. 2017;17(22):2495–2508.
   PubMed Web of Science ®Google Scholar
• Margis R, Dunand C, Teixeira FK, et al. Glutathione peroxidase family - an evolutionary overview. FEBS J. 2008;275(15):3959–3970.
   PubMed Web of Science ®Google Scholar
• Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005;15(4):316–328.
   PubMed Web of Science ®Google Scholar
• Koyani CN, Plastira I, Sourij H, et al. Empagliflozin protects heart from inflammation and energy depletion via AMPK activation. Pharmacol Res. 2020;158:104870.
   PubMed Web of Science ®Google Scholar